syndrome	score	normalized_score
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	2.5	100.0
#168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC;;PARALYSIS PERIODICA PARAMYOTONICAPARAMYOTONIA CONGENITA WITHOUT COLD PARALYSIS, INCLUDED	1.75555556	70.2222224
MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	1.75	70.0
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	1.333333	53.33332000000001
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	1.25555556	50.22222239999999
NEMALINE MYOPATHY 7; NEM7	1.1457757	45.831027999999996
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	1.125	45.0
BARTH SYNDROME; BTHS	1.04020399	41.6081596
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	1.02479028	40.9916112
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	1.0	40.0
RIPPLING MUSCLE DISEASE; RMD	1.0	40.0
BUTYRYLCHOLINESTERASE	1.0	40.0
#604715 ORTHOSTATIC INTOLERANCE;;NEUROCIRCULATORY ASTHENIA;;MITRAL VALVE PROLAPSE SYNDROME;;IRRITABLE HEART;;SOLDIERS HEART	1.0	40.0
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0	40.0
RIPPLING MUSCLE DISEASE 1; RMD1	1.0	40.0
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0	40.0
YOU-HOOVER-FONG SYNDROME; YHFS	1.0	40.0
HORNER SYNDROME, CONGENITAL	1.0	40.0
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0	40.0
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	1.0	40.0
SYRINGOMYELIA, ISOLATED	0.666667	26.66668
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.56087475	22.43499
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.5606059999999999	22.424239999999998
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.5570273	22.281092
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.5555556	22.222224
CHIARI MALFORMATION TYPE I	0.5217391	20.869564
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.50617284	20.2469136
INCLUSION BODY MYOSITIS	0.504329	20.173160000000003
RIGID SPINE MUSCULAR DYSTROPHY 1	0.5	20.0
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	20.0
#608895 MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	0.5	20.0
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.458333	18.33332
STUVE-WIEDEMANN SYNDROME	0.45686059	18.2744236
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.44444399999999995	17.777759999999997
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.39416132	15.7664528
#615575 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D;;HMN IID;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;;SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	0.3888886	15.555544
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.36551349	14.620539599999999
#608810 MYOPATHY, MYOFIBRILLAR, 2, MFM2;;MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;;MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;;ALPHA-B CRYSTALLINOPATHY	0.36363599999999996	14.54544
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.34195369	13.678147599999999
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.33865215	13.546085999999999
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.337662	13.506480000000002
Pierpont syndrome	0.333333	13.333319999999999
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.333333	13.333319999999999
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.333333	13.333319999999999
MUNGAN SYNDROME	0.333333	13.333319999999999
CHROMOSOME 16p13.2 DELETION SYNDROME	0.333333	13.333319999999999
PHELAN-MCDERMID SYNDROME; PHMDS	0.29823971999999993	11.929588799999998
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.25964815	10.385926000000001
#609452 MYOPATHY, MYOFIBRILLAR, 4; MFM4;;MYOPATHY, MYOFIBRILLAR, ZASP-RELATED	0.2578671	10.314684
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.25396799999999997	10.158719999999999
OPTIC ATROPHY 5; OPA5	0.25	10.0
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.25	10.0
#613587 OCCULT MACULAR DYSTROPHY; OCMD;;OMD	0.25	10.0
CONE-ROD DYSTROPHY 11; CORD11	0.25	10.0
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.233496	9.33984
MYOTILINOPATHY	0.23288325	9.315330000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.22248231999999998	8.8992928
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.21064816000000003	8.425926400000002
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.20535699999999998	8.214279999999999
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.2027416	8.109664
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.19548859999999998	7.819543999999999
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.17871555999999997	7.148622399999999
SPINAL MUSCULAR ATROPHY, TYPE II	0.17222256	6.888902399999999
PHACE ASSOCIATION	0.166667	6.6666799999999995
%109500 BASILAR IMPRESSION, PRIMARY	0.166667	6.6666799999999995
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.166667	6.6666799999999995
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.166667	6.6666799999999995
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.166667	6.6666799999999995
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.166667	6.6666799999999995
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.166667	6.6666799999999995
GLYCEROL KINASE DEFICIENCY; GKD	0.16073695	6.429478
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.159632	6.38528
#613376 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C;;HMN IIC;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC;;DHMN2C	0.1591666	6.366664
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.1591666	6.366664
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.1591666	6.366664
MACHADO-JOSEPH DISEASE; MJD	0.15458929999999999	6.183572
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.15211625999999998	6.084650399999999
DUBOWITZ SYNDROME	0.15105371999999997	6.042148799999999
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.14841255999999997	5.936502399999998
AGNATHIA-OTOCEPHALY COMPLEX	0.1477273	5.909092
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.1458333	5.833332
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.1458333	5.833332
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.1458333	5.833332
HEMIFACIAL MICROSOMIA	0.14285699999999998	5.71428
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.14285699999999998	5.71428
#613630 COCOON SYNDROME;;FETAL ENCASEMENT SYNDROME	0.14285699999999998	5.71428
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.14285699999999998	5.71428
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.14285699999999998	5.71428
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.14285699999999998	5.71428
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.14285699999999998	5.71428
MICROTIA-ANOTIA	0.14285699999999998	5.71428
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.14285699999999998	5.71428
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.14285699999999998	5.71428
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.14285699999999998	5.71428
#615297 ADAMS-OLIVER SYNDROME 4; AOS4	0.14285699999999998	5.71428
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.14285699999999998	5.71428
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.14285699999999998	5.71428
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.14285699999999998	5.71428
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.14285699999999998	5.71428
#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	0.13858826	5.5435304
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.13749848	5.4999392
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.13624346	5.4497384
SMITH-MAGENIS SYNDROME; SMS	0.13464815	5.3859259999999995
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.13362069	5.3448275999999995
WHITE-SUTTON SYNDROME; WHSUS	0.13319672	5.3278688
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.13034179999999998	5.213671999999999
#269400 CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;;SCLEROCORNEA WITH OTHER OCULAR ANOMALIES	0.125	5.0
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.125	5.0
WITTEVEEN-KOLK SYNDROME	0.125	5.0
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.125	5.0
EHLERS-DANLOS SYNDROME, TYPE I	0.125	5.0
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.125	5.0
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	0.125	5.0
ACROCRANIOFACIAL DYSOSTOSIS	0.125	5.0
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.125	5.0
WILDERVANCK SYNDROME	0.125	5.0
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.125	5.0
#615348 NEMALINE MYOPATHY 8; NEM8	0.125	5.0
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.125	5.0
CONE-ROD DYSTROPHY 2	0.1232558	4.930231999999999
CONE-ROD DYSTROPHY 10	0.1222222	4.888888000000001
MYOPATHY, SPHEROID BODY	0.12037025999999999	4.8148104
PRADER-WILLI SYNDROME; PWS	0.11973168999999999	4.7892676
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.11805560000000001	4.722224000000001
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.11805560000000001	4.722224000000001
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.1161616	4.646464
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.11543999999999999	4.6175999999999995
ERYTHERMALGIA, PRIMARY	0.11497779999999999	4.599112
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.11385398999999999	4.554159599999999
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.11363630000000001	4.545452000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.11111099999999999	4.444439999999999
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.11111099999999999	4.444439999999999
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.11111099999999999	4.444439999999999
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.11111099999999999	4.444439999999999
PERRY SYNDROME	0.11111099999999999	4.444439999999999
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.11111099999999999	4.444439999999999
OBESITY-HYPOVENTILATION SYNDROME	0.11111099999999999	4.444439999999999
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.11111099999999999	4.444439999999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.11111099999999999	4.444439999999999
OPTIC ATROPHY 2	0.11111099999999999	4.444439999999999
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.11111099999999999	4.444439999999999
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.10785736000000001	4.3142944000000005
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.1056619	4.226476
#613767 RETINITIS PIGMENTOSA 45; RP45	0.1	4.0
Retinitis pigmentosa with or without skeletal anomalies	0.1	4.0
RETINITIS PIGMENTOSA 41	0.1	4.0
RETINITIS PIGMENTOSA 58	0.1	4.0
CONE-ROD DYSTROPHY 6; CORD6	0.1	4.0
#613810 RETINITIS PIGMENTOSA 43; RP43	0.1	4.0
RETINITIS PIGMENTOSA 75; RP75	0.1	4.0
CONE-ROD DYSTROPHY 8; CORD8	0.1	4.0
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.0936508	3.7460320000000005
MYOPATHY, DISTAL, 5; MPD5	0.09259256000000002	3.703702400000001
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.08993385000000001	3.5973540000000006
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.08585860000000001	3.4343440000000003
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.08333330000000001	3.333332000000001
MYOPATHY, SCAPULOHUMEROPERONEAL	0.08107675	3.24307
MUSCULAR DYSTROPHY, BARNES TYPE	0.08068786000000001	3.2275144000000004
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.08015513999999999	3.206205599999999
CHYLOMICRON RETENTION DISEASE	0.07867498	3.1469992
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.07867498	3.1469992
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0785956	3.143824
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.07729470000000001	3.091788
CRANIOSYNOSTOSIS 2	0.07729470000000001	3.091788
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.07698416000000001	3.0793664000000005
GLYCOGEN STORAGE DISEASE IV	0.07698416000000001	3.0793664000000005
EPISODIC ATAXIA, TYPE 2	0.07698416000000001	3.0793664000000005
MYOTONIC DYSTROPHY 1	0.07698416000000001	3.0793664000000005
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.07591922	3.0367687999999995
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.07575760000000001	3.030304
NEMALINE MYOPATHY 6	0.07471585	2.9886340000000002
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.0743707	2.974828
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.07309950000000001	2.9239800000000002
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.0721568	2.886272
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.0721568	2.886272
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.07186239999999999	2.8744959999999997
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.07142860000000001	2.8571440000000004
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.07142860000000001	2.8571440000000004
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.07142860000000001	2.8571440000000004
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.07142860000000001	2.8571440000000004
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.07142860000000001	2.8571440000000004
POSTERIOR COLUMN ATAXIA	0.07142860000000001	2.8571440000000004
DYSTROPHIA MYOTONICA 2	0.07142860000000001	2.8571440000000004
NORMOKALEMIC PERIODIC PARALYSIS	0.07142860000000001	2.8571440000000004
MYOTONIA, POTASSIUM-AGGRAVATED	0.07142860000000001	2.8571440000000004
HYPERKALEMIC PERIODIC PARALYSIS; HYPP	0.07142860000000001	2.8571440000000004
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.07142860000000001	2.8571440000000004
#615558 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1;;HYPOBETALIPOPROTEINEMIA, FAMILIAL; FHBL;;ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA;;HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	0.07142860000000001	2.8571440000000004
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.07142860000000001	2.8571440000000004
BETHLEM MYOPATHY 2; BTHLM2	0.07037042	2.8148168
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.07013401	2.8053604
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.06872449	2.7489796
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.06872449	2.7489796
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.06872449	2.7489796
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.06867284	2.7469135999999996
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.06744419	2.6977675999999997
PEROXISOME BIOGENESIS DISORDER 5B	0.06605744	2.6422975999999996
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.06520375	2.60815
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.06520375	2.60815
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.06520375	2.60815
SANDHOFF DISEASE	0.06437906	2.5751624
SCLEROSTEOSIS 1; SOST1	0.0625388	2.501552
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.06253259	2.5013036
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0625	2.5
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0625	2.5
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.06227975	2.49119
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.060874750000000005	2.43499
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.06082832	2.4331328
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.06082832	2.4331328
TURNPENNY-FRY SYNDROME; TPFS	0.06082832	2.4331328
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0588235	2.35294
#610600 CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY;;CMO II DEFICIENCY;;ALDOSTERONE DEFICIENCY II;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1B;;ALDOSTERONE DEFICIENCY DUE TO DEFICIENCY OF STEROID 18-OXIDASE;;STEROID 18-OXIDASE DEFICIENCY;;18-@OXIDASE DEFICIENCY	0.0588235	2.35294
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.0588235	2.35294
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0588235	2.35294
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.0588235	2.35294
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.0588235	2.35294
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.0588235	2.35294
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.057597659999999995	2.3039064
DYSAUTONOMIA-LIKE DISORDER	0.056811600000000004	2.2724640000000003
CAVITARY OPTIC DISC ANOMALIES; CODA	0.055555600000000004	2.222224
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.055555600000000004	2.222224
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.055555600000000004	2.222224
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.055555600000000004	2.222224
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.055555600000000004	2.222224
#613809 RETINITIS PIGMENTOSA 39; RP39	0.055555600000000004	2.222224
RETINITIS PIGMENTOSA 78; RP78	0.055555600000000004	2.222224
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.055555600000000004	2.222224
RETINITIS PIGMENTOSA 62; RP62	0.055555600000000004	2.222224
#615725 RETINITIS PIGMENTOSA 68; RP68	0.055555600000000004	2.222224
RETINITIS PIGMENTOSA 4; RP4	0.055555600000000004	2.222224
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.055555600000000004	2.222224
USHER SYNDROME, TYPE IIIA	0.055555600000000004	2.222224
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.055555600000000004	2.222224
#609923 RETINITIS PIGMENTOSA 31; RP31	0.055555600000000004	2.222224
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.05337929	2.1351716
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.053126450000000006	2.125058
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0526316	2.105264
MARSHALL-SMITH SYNDROME; MRSHSS	0.0526316	2.105264
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0526316	2.105264
NETHERTON SYNDROME; NETH	0.0526316	2.105264
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.0526316	2.105264
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0526316	2.105264
XIA-GIBBS SYNDROME	0.0526316	2.105264
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0526316	2.105264
HALLERMANN-STREIFF SYNDROME; HSS	0.0526316	2.105264
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0526316	2.105264
SCHEIE SYNDROME	0.0526316	2.105264
THROMBOCYTOPENIA 1	0.0526316	2.105264
MARFANOID HABITUS WITH SITUS INVERSUS	0.0526316	2.105264
APNEA, OBSTRUCTIVE SLEEP	0.0526316	2.105264
CRAMPS, FAMILIAL ADOLESCENT	0.0526316	2.105264
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0526316	2.105264
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0526316	2.105264
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0526316	2.105264
DYSOSTEOSCLEROSIS	0.0526316	2.105264
#227600 FACTOR X DEFICIENCY;;F10 DEFICIENCY;;STUART-PROWER FACTOR DEFICIENCY	0.0526316	2.105264
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0526316	2.105264
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0526316	2.105264
COSTELLO SYNDROME; CSTLO	0.0526316	2.105264
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0526316	2.105264
HYDROXYKYNURENINURIA	0.0526316	2.105264
HURLER-SCHEIE SYNDROME	0.0526316	2.105264
ROWLEY-ROSENBERG SYNDROME	0.0526316	2.105264
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.052042099999999994	2.0816839999999996
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.052042099999999994	2.0816839999999996
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.052042099999999994	2.0816839999999996
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.052042099999999994	2.0816839999999996
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.05185909	2.0743636
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.051724349999999995	2.068974
PITT-HOPKINS SYNDROME	0.05167502	2.0670008
Fabry disease	0.05072468000000001	2.0289872000000004
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.04919186	1.9676744
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.049033860000000005	1.9613544000000003
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.048824679999999995	1.9529871999999997
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.0478469	1.9138759999999997
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.047807300000000004	1.912292
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.04701248	1.8804992
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.04612399	1.8449596
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.04603396	1.8413584
#303100 CHOROIDEREMIA; CHM;;TAPETOCHOROIDAL DYSTROPHY, PROGRESSIVE; TCDCHOROIDAL SCLEROSIS, INCLUDED	0.045478000000000005	1.81912
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.045478000000000005	1.81912
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.045478000000000005	1.81912
SENGERS SYNDROME	0.045117819999999996	1.8047128
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0439613	1.758452
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.043478300000000004	1.7391320000000001
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.043478300000000004	1.7391320000000001
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.043478300000000004	1.7391320000000001
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.043478300000000004	1.7391320000000001
PARKINSON DISEASE, LATE-ONSET; PD	0.043478300000000004	1.7391320000000001
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.043478300000000004	1.7391320000000001
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.043478300000000004	1.7391320000000001
Adult-onset autosomal dominant leukodystrophy (ADLD)	0.043478300000000004	1.7391320000000001
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.043478300000000004	1.7391320000000001
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.043478300000000004	1.7391320000000001
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.043478300000000004	1.7391320000000001
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.043478300000000004	1.7391320000000001
GITELMAN SYNDROME	0.043104939999999994	1.7241975999999999
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0415952	1.663808
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.040969900000000004	1.638796
ALSTROM SYNDROME; ALMS	0.0407997	1.6319880000000002
#604232 LEBER CONGENITAL AMAUROSIS 3; LCA3RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED, INCLUDED	0.0407997	1.6319880000000002
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.04077819	1.6311276
NONAKA MYOPATHY	0.040203989999999995	1.6081595999999996
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.03995115	1.5980459999999999
NEMALINE MYOPATHY 2; NEM2	0.03995115	1.5980459999999999
NEMALINE MYOPATHY 3; NEM3	0.03995115	1.5980459999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.039562259999999995	1.5824903999999997
WILLIAMS-BEUREN SYNDROME; WBS	0.03903961	1.5615844
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.03892369	1.5569476
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.03892369	1.5569476
#616000 ANALBUMINEMIA; ANALBA	0.03892369	1.5569476
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.03788325	1.51533
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.0376653	1.5066119999999998
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.03754937999999999	1.5019751999999997
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0371822	1.487288
Adrenoleukodystrophy	0.0367747	1.470988
CHROMOSOME 1P36 DELETION SYNDROME	0.03659176	1.4636704
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.036475839999999995	1.4590336
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.036475839999999995	1.4590336
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.03645219	1.4580876
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.03636174	1.4544696
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.03619635	1.4478540000000002
FONTAINE PROGEROID SYNDROME; FPS	0.03597448	1.4389792000000001
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.03585856	1.4343423999999998
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.03585856	1.4343423999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.03585856	1.4343423999999998
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.03585856	1.4343423999999998
MYXEDEMA	0.03585856	1.4343423999999998
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.03562215	1.4248859999999999
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.03562215	1.4248859999999999
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.03562215	1.4248859999999999
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.03509787	1.4039148000000001
NEUROFIBROMATOSIS, TYPE II	0.035072400000000004	1.4028960000000001
Polyarteritis nodosa, childhood-onset	0.035072400000000004	1.4028960000000001
COCKAYNE SYNDROME A; CSA	0.03468735	1.3874939999999998
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.034631999999999996	1.3852799999999998
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.034631999999999996	1.3852799999999998
EPISODIC ATAXIA, TYPE 3	0.03454104	1.3816416000000002
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.03443451	1.3773804
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.03340705	1.3362820000000002
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.03309691	1.3238764
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.03237545	1.295018
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.03224071	1.2896284
PEROXISOME BIOGENESIS DISORDER 3B	0.03218049	1.2872195999999998
BEHR SYNDROME	0.03212319	1.2849276
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.03210676	1.2842704
Boucher-Neuhauser syndrome	0.03187035	1.274814
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.03164009	1.2656036000000002
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.031178169999999998	1.2471268
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0309592	1.238368
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.030924019999999997	1.2369607999999999
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.030924019999999997	1.2369607999999999
LEBER OPTIC ATROPHY AND DYSTONIA	0.0308772	1.235088
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.03084289	1.2337156
CRANIOECTODERMAL DYSPLASIA 1	0.03084289	1.2337156
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.03084289	1.2337156
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.03084289	1.2337156
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.03084289	1.2337156
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.03072279	1.2289116
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.030646809999999997	1.2258723999999999
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.030418920000000002	1.2167568
CORNELIA DE LANGE SYNDROME 3	0.030418920000000002	1.2167568
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.030302999999999997	1.2121199999999999
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.030302999999999997	1.2121199999999999
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.030302999999999997	1.2121199999999999
HEMOCHROMATOSIS, TYPE 4; HFE4	0.030302999999999997	1.2121199999999999
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.030302999999999997	1.2121199999999999
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.030302999999999997	1.2121199999999999
NEMALINE MYOPATHY 1; NEM1	0.030302999999999997	1.2121199999999999
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.030302999999999997	1.2121199999999999
EXCHONDROSIS OF PINNA, POSTERIOR	0.030302999999999997	1.2121199999999999
AREDYLD	0.030302999999999997	1.2121199999999999
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.030302999999999997	1.2121199999999999
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.030302999999999997	1.2121199999999999
DARWINIAN TUBERCLE OF PINNA	0.030302999999999997	1.2121199999999999
MUSICAL PERFECT PITCH	0.030302999999999997	1.2121199999999999
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.030302999999999997	1.2121199999999999
SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	0.030302999999999997	1.2121199999999999
ALKAPTONURIA	0.030302999999999997	1.2121199999999999
EAR FOLDING	0.030302999999999997	1.2121199999999999
HAIRY EARS, Y-LINKED	0.030302999999999997	1.2121199999999999
EAR WITHOUT HELIX	0.030302999999999997	1.2121199999999999
HEMOCHROMATOSIS, TYPE 3; HFE3	0.030302999999999997	1.2121199999999999
EAR ANTITRAGUS, TAG AT BASE OF	0.030302999999999997	1.2121199999999999
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.030302999999999997	1.2121199999999999
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.030302999999999997	1.2121199999999999
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.030302999999999997	1.2121199999999999
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.030302999999999997	1.2121199999999999
EAR MALFORMATION	0.030302999999999997	1.2121199999999999
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.030302999999999997	1.2121199999999999
VELOCARDIOFACIAL SYNDROME	0.030302999999999997	1.2121199999999999
ANISOCORIA	0.030302999999999997	1.2121199999999999
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.030302999999999997	1.2121199999999999
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.030302999999999997	1.2121199999999999
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.030302999999999997	1.2121199999999999
EAR WAX, WET/DRY	0.030302999999999997	1.2121199999999999
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.030302999999999997	1.2121199999999999
MYOPATHY, DISTAL 3	0.030302999999999997	1.2121199999999999
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.030302999999999997	1.2121199999999999
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.030302999999999997	1.2121199999999999
SATOYOSHI SYNDROME	0.030302999999999997	1.2121199999999999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.030302999999999997	1.2121199999999999
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.030302999999999997	1.2121199999999999
#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	0.030302999999999997	1.2121199999999999
BLAU SYNDROME	0.030302999999999997	1.2121199999999999
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.030302999999999997	1.2121199999999999
ADIPOSIS DOLOROSA	0.030302999999999997	1.2121199999999999
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.030302999999999997	1.2121199999999999
#255160 MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB;;MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE	0.030302999999999997	1.2121199999999999
OSSIFIED EAR CARTILAGES	0.030302999999999997	1.2121199999999999
FRYNS MICROPHTHALMIA SYNDROME	0.030302999999999997	1.2121199999999999
DARWINIAN POINT OF PINNA	0.030302999999999997	1.2121199999999999
OTOONYCHOPERONEAL SYNDROME	0.030302999999999997	1.2121199999999999
ROSSELLI-GULIENETTI SYNDROME	0.030302999999999997	1.2121199999999999
OSTEOMA OF MIDDLE EAR	0.030302999999999997	1.2121199999999999
PEROXISOME BIOGENESIS DISORDER 14B	0.030105510000000002	1.2042204
HYPERCALCEMIA, INFANTILE, 1	0.02997368	1.1989471999999999
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.029935820000000002	1.1974328
RETINAL CONE DYSTROPHY 4	0.02942864	1.1771456
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.02942864	1.1771456
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.02911536	1.1646144
#613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATIONAND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	0.02911536	1.1646144
PAPILLOMA OF CHOROID PLEXUS	0.02898548	1.1594191999999999
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.02898548	1.1594191999999999
HYPER-IGD SYNDROME	0.02898548	1.1594191999999999
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.02898548	1.1594191999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.02887895	1.1551580000000001
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.02855344	1.1421376
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.028490059999999998	1.1396024
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.02839504	1.1358016
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.02828286	1.1313144000000002
MYOPATHY, CONGENITAL	0.02812716	1.1250863999999998
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.02785149	1.1140595999999998
WILSON DISEASE	0.02785149	1.1140595999999998
NEURAMINIDASE DEFICIENCY	0.027777760000000002	1.1111104
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.02744489	1.0977956
MYOCLONIC EPILEPSY OF LAFORA	0.02744489	1.0977956
#613882 HYPOMAGNESEMIA 6, RENAL; HOMG6	0.027294660000000002	1.0917864000000002
CAMURATI-ENGELMANN DISEASE	0.027294660000000002	1.0917864000000002
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.026921559999999997	1.0768624
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.02680316	1.0721264
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0265512	1.0620479999999999
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.02647718	1.0590872
NIEMANN-PICK DISEASE, TYPE A	0.02575163	1.0300652000000001
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.02574062	1.0296248
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.02534409	1.0137636
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.02504074	1.0016296
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.02479028	0.9916112000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.02479028	0.9916112000000001
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.02478636	0.9914544000000001
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.02454995	0.981998
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.02454995	0.981998
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.02454995	0.981998
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02442346	0.9769384000000001
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.02371674	0.9486695999999999
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.02371674	0.9486695999999999
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.02371674	0.9486695999999999
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.02371674	0.9486695999999999
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.0235598	0.9423919999999999
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0235598	0.9423919999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0235598	0.9423919999999999
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0235598	0.9423919999999999
CHERUBISM	0.0232558	0.930232
RETINITIS PIGMENTOSA 25; RP25	0.0232558	0.930232
RETINITIS PIGMENTOSA 11	0.0232558	0.930232
GLAUCOMA 1, OPEN ANGLE, M	0.0232558	0.930232
RETINITIS PIGMENTOSA 19	0.0232558	0.930232
CONE-ROD DYSTROPHY 20; CORD20	0.0232558	0.930232
RETINITIS PIGMENTOSA 6	0.0232558	0.930232
RETINITIS PIGMENTOSA 10; RP10	0.0232558	0.930232
RETINITIS PIGMENTOSA 14	0.0232558	0.930232
RETINITIS PIGMENTOSA 73; RP73	0.0232558	0.930232
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0232558	0.930232
RETINITIS PIGMENTOSA 83; RP83	0.0232558	0.930232
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0232558	0.930232
#612572 RETINITIS PIGMENTOSA 46; RP46;;RETINITIS PIGMENTOSA, AUTOSOMAL RECESSIVE, IDH3B-RELATED	0.0232558	0.930232
RETINITIS PIGMENTOSA	0.0232558	0.930232
#608380 RETINITIS PIGMENTOSA 26; RP26	0.0232558	0.930232
#312600 RETINITIS PIGMENTOSA 2; RP2	0.0232558	0.930232
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0232558	0.930232
RETINITIS PIGMENTOSA 1	0.0232558	0.930232
#608133 RETINITIS PIGMENTOSA 7; RP7RETINITIS PIGMENTOSA 7, DIGENIC, INCLUDED;;RETINITIS PIGMENTOSA 7 WITH BULL'S-EYE MACULOPATHY, INCLUDED	0.0232558	0.930232
#180104 RETINITIS PIGMENTOSA 9; RP9	0.0232558	0.930232
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.0232558	0.930232
BARDET-BIEDL SYNDROME 21; BBS21	0.0232558	0.930232
RETINITIS PIGMENTOSA 79	0.0232558	0.930232
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.0232558	0.930232
RETINITIS PIGMENTOSA 74; RP74	0.0232558	0.930232
#613769 RETINITIS PIGMENTOSA 44; RP44	0.0232558	0.930232
#615233 RETINITIS PIGMENTOSA 66; RP66	0.0232558	0.930232
#606068 RETINITIS PIGMENTOSA 28; RP28	0.0232558	0.930232
RETINITIS PIGMENTOSA 13; RP13	0.0232558	0.930232
RETINITIS PIGMENTOSA 69	0.0232558	0.930232
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.0232558	0.930232
RETINITIS PIGMENTOSA 72; RP72	0.0232558	0.930232
MOEBIUS SYNDROME; MBS	0.023234289999999998	0.9293715999999999
MAST SYNDROME	0.023234289999999998	0.9293715999999999
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.02321786	0.9287144
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.02321786	0.9287144
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.02321786	0.9287144
PEROXISOME BIOGENESIS DISORDER 11B	0.023099460000000002	0.9239784000000001
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.023099460000000002	0.9239784000000001
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.02298145	0.919258
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.02298145	0.919258
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.02298145	0.919258
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.02298145	0.919258
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.02298145	0.919258
#118210 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A1;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA1;;HMSN IIA1;;HMSN2A1	0.02298145	0.919258
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.022863050000000003	0.9145220000000001
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.022863050000000003	0.9145220000000001
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0227273	0.9090919999999999
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0227273	0.9090919999999999
CARNEY COMPLEX, TYPE 1; CNC1	0.0227273	0.9090919999999999
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0227273	0.9090919999999999
OSTEOGENESIS IMPERFECTA, TYPE V	0.0227273	0.9090919999999999
STICKLER SYNDROME, TYPE III	0.0227273	0.9090919999999999
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0227273	0.9090919999999999
OCULAR CICATRICIAL PEMPHIGOID	0.0227273	0.9090919999999999
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0227273	0.9090919999999999
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.0227273	0.9090919999999999
GAUCHER DISEASE, TYPE I	0.0227273	0.9090919999999999
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.9090919999999999
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0227273	0.9090919999999999
611426 TENTED EYEBROWS	0.0227273	0.9090919999999999
IMINOGLYCINURIA	0.0227273	0.9090919999999999
DERMOIDS OF CORNEA	0.0227273	0.9090919999999999
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0227273	0.9090919999999999
MYELINATED OPTIC NERVE FIBERS	0.0227273	0.9090919999999999
#184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE;;SED, MAROTEAUX TYPE;;PSEUDO-MORQUIO SYNDROME, TYPE 2	0.0227273	0.9090919999999999
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0227273	0.9090919999999999
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0227273	0.9090919999999999
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0227273	0.9090919999999999
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0227273	0.9090919999999999
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0227273	0.9090919999999999
BLEPHAROCHALASIS AND DOUBLE LIP	0.0227273	0.9090919999999999
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0227273	0.9090919999999999
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0227273	0.9090919999999999
SEA-BLUE HISTIOCYTE DISEASE	0.0227273	0.9090919999999999
MELANOMA, CUTANEOUS MALIGNANT	0.0227273	0.9090919999999999
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0227273	0.9090919999999999
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0227273	0.9090919999999999
MELKERSSON-ROSENTHAL SYNDROME	0.0227273	0.9090919999999999
UNIQUE GREEN PHENOMENON	0.0227273	0.9090919999999999
PUPIL, EGG-SHAPED	0.0227273	0.9090919999999999
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0227273	0.9090919999999999
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.022592559999999998	0.9037023999999999
CONE DYSTROPHY 3	0.0222222	0.888888
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0222222	0.888888
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0222222	0.888888
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.0222222	0.888888
AORTIC VALVE DISEASE 2; AOVD2	0.0222222	0.888888
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.0222222	0.888888
Contractural arachnodactyly, congenital	0.0222222	0.888888
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.0222222	0.888888
JOUBERT SYNDROME 35; JBTS35	0.0222222	0.888888
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0222222	0.888888
HUNTER-MACDONALD SYNDROME	0.0222222	0.888888
RETINITIS PIGMENTOSA 80; RP80	0.0222222	0.888888
#613660 CONE-ROD DYSTROPHY 15; CORD15RETINITIS PIGMENTOSA 65, INCLUDED; RP65, INCLUDED	0.0222222	0.888888
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.0222222	0.888888
AORTIC VALVE DISEASE 1; AOVD1	0.0222222	0.888888
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0222222	0.888888
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.0222222	0.888888
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.0222222	0.888888
CONE-ROD DYSTROPHY 16	0.0222222	0.888888
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.0222222	0.888888
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0222222	0.888888
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.0222222	0.888888
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.0222222	0.888888
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.0222222	0.888888
AORTIC VALVE DISEASE 3; AOVD3	0.0222222	0.888888
LATERAL MENINGOCELE SYNDROME	0.0222222	0.888888
CORNEAL DYSTROPHY, LATTICE TYPE I	0.0222222	0.888888
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0222222	0.888888
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0222222	0.888888
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0222222	0.888888
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.0222222	0.888888
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0222222	0.888888
#613426 CARDIOMYOPATHY, DILATED, 1S; CMD1SLEFT VENTRICULAR NONCOMPACTION 5, INCLUDED; LVNC5, INCLUDED	0.0222222	0.888888
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.0222222	0.888888
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.0222222	0.888888
#613862 RETINITIS PIGMENTOSA 38; RP38;;ROD-CONE DYSTROPHY, CHILDHOOD-ONSET	0.0222222	0.888888
Bardet-Biedl syndrome 2	0.0222222	0.888888
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0222222	0.888888
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0222222	0.888888
MICROPHTHALMIA, SYNDROMIC 1	0.0222222	0.888888
KOOLEN-DE VRIES SYNDROME; KDVS	0.0222222	0.888888
ATRIAL SEPTAL DEFECT 1	0.0222222	0.888888
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.0222222	0.888888
BASAL LAMINAR DRUSEN	0.0222222	0.888888
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.0222222	0.888888
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.0222222	0.888888
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.0222222	0.888888
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.0222222	0.888888
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.0222222	0.888888
ANIRIDIA 3	0.0222222	0.888888
ADAMS-OLIVER SYNDROME 1; AOS1	0.0222222	0.888888
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.0222222	0.888888
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0222222	0.888888
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.0222222	0.888888
RETINAL CONE DYSTROPHY 1; RCD1	0.0222222	0.888888
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0222222	0.888888
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.0222222	0.888888
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0222222	0.888888
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0222222	0.888888
GRANGE SYNDROME; GRNG	0.0222222	0.888888
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.0222222	0.888888
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.0222222	0.888888
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0222222	0.888888
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.022061200000000003	0.8824480000000001
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.02195399	0.8781595999999999
FLYNN-AIRD SYNDROME	0.02195399	0.8781595999999999
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.0217391	0.8695640000000001
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.0217391	0.8695640000000001
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0217391	0.8695640000000001
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.0217391	0.8695640000000001
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0217391	0.8695640000000001
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.0217391	0.8695640000000001
PARIETAL FORAMINA	0.0217391	0.8695640000000001
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0217391	0.8695640000000001
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.0217391	0.8695640000000001
GLUTAMATE MONOSODIUM SENSITIVITY	0.0217391	0.8695640000000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.0217391	0.8695640000000001
MARSILI SYNDROME; MARSIS	0.0217391	0.8695640000000001
SNEDDON SYNDROME	0.0217391	0.8695640000000001
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0217391	0.8695640000000001
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0217391	0.8695640000000001
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.0217391	0.8695640000000001
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0217391	0.8695640000000001
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.0217391	0.8695640000000001
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.0217391	0.8695640000000001
BRUNNER SYNDROME; BRNRS	0.0217391	0.8695640000000001
EPISODIC ATAXIA, TYPE 1; EA1	0.0217391	0.8695640000000001
LYSINURIC PROTEIN INTOLERANCE; LPI	0.02142263	0.8569052
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.02057968	0.8231871999999999
PORPHYRIA VARIEGATA	0.02057968	0.8231871999999999
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.02040283	0.8161132
MCLEOD SYNDROME; MCLDS	0.02013397	0.8053588
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.01978555	0.791422
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.01954914	0.7819655999999999
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.01954914	0.7819655999999999
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.01954914	0.7819655999999999
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.01954914	0.7819655999999999
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.019506139999999998	0.7802456
SPINOCEREBELLAR ATAXIA 23; SCA23	0.0192308	0.769232
46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	0.0192308	0.769232
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.0192308	0.769232
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0192308	0.769232
AMYLOIDOSIS, FINNISH TYPE	0.0192308	0.769232
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0192308	0.769232
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0192308	0.769232
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.0192308	0.769232
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.0192308	0.769232
APOLIPOPROTEIN A-I; APOA1	0.0192308	0.769232
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.0192308	0.769232
WERNICKE-KORSAKOFF SYNDROME	0.0192308	0.769232
WAARDENBURG-SHAH SYNDROME	0.0192308	0.769232
MONONEUROPATHY OF THE MEDIAN NERVE, MILD	0.0192308	0.769232
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.0192308	0.769232
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.01916025	0.76641
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.01916025	0.76641
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.01916025	0.76641
MYOPATHY, DISTAL, 4; MPD4	0.01914382	0.7657527999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.01890741	0.7562964
STIFF SKIN SYNDROME	0.01888886	0.7555544
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.7547159999999999
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.7547159999999999
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.7547159999999999
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.7547159999999999
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	0.7547159999999999
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.7547159999999999
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.7547159999999999
TRANSSEXUALITY	0.0188679	0.7547159999999999
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.7547159999999999
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	0.7547159999999999
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.7547159999999999
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	0.7547159999999999
RHEUMATOID ARTHRITIS	0.0188679	0.7547159999999999
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.7547159999999999
CARDIAC ARRHYTHMIA	0.0188679	0.7547159999999999
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.7547159999999999
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.7547159999999999
PALMOMENTAL REFLEX	0.0188679	0.7547159999999999
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.7547159999999999
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	0.7547159999999999
THUMBS, CONGENITAL CLASPED	0.0188679	0.7547159999999999
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.7547159999999999
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.7547159999999999
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.7547159999999999
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.7547159999999999
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.7547159999999999
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.7547159999999999
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.7547159999999999
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	0.7547159999999999
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.7547159999999999
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.7547159999999999
CERVICAL RIB	0.0188679	0.7547159999999999
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.7547159999999999
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.7547159999999999
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.7547159999999999
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.7547159999999999
DIASTEMATOMYELIA	0.0188679	0.7547159999999999
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.7547159999999999
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.7547159999999999
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.7547159999999999
MOTION SICKNESS	0.0188679	0.7547159999999999
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.7547159999999999
269800 SENILE PLAQUE FORMATION	0.0188679	0.7547159999999999
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.7547159999999999
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.7547159999999999
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.7547159999999999
ALCOHOL DEPENDENCE	0.0188679	0.7547159999999999
JUMPING FRENCHMAN OF MAINE	0.0188679	0.7547159999999999
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.018698559999999996	0.7479423999999999
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.01865245	0.746098
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.01865245	0.746098
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.01865245	0.746098
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01865245	0.746098
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.01865245	0.746098
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.01865245	0.746098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.01865245	0.746098
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.01826884	0.7307536000000001
TENORIO SYNDROME; TNORS	0.01809771	0.7239084
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.01809771	0.7239084
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.01787995	0.715198
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0176623	0.706492
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0176623	0.706492
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0176623	0.706492
#158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY	0.0176623	0.706492
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.0176623	0.706492
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0175439	0.701756
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0175439	0.701756
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.0175439	0.701756
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0175439	0.701756
CATARACT 44; CTRCT44	0.0175439	0.701756
CATARACT 7; CTRCT7	0.0175439	0.701756
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0175439	0.701756
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.0175439	0.701756
OPTIC ATROPHY 8	0.0175439	0.701756
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0175439	0.701756
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.0175439	0.701756
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0175439	0.701756
RETINOSCHISIS OF FOVEA	0.0175439	0.701756
SENIOR-LOKEN SYNDROME 3	0.0175439	0.701756
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.0175439	0.701756
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0175439	0.701756
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0175439	0.701756
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0175439	0.701756
#604116 CONE-ROD DYSTROPHY 3; CORD3	0.0175439	0.701756
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0175439	0.701756
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.0175439	0.701756
BRITTLE CORNEA SYNDROME	0.0175439	0.701756
LATE-ONSET RETINAL DEGENERATION; LORD	0.0175439	0.701756
NANCE-HORAN SYNDROME	0.0175439	0.701756
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0175439	0.701756
KNOBLOCH SYNDROME 1; KNO1	0.0175439	0.701756
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0175439	0.701756
OPTICOCOCHLEODENTATE DEGENERATION	0.0175439	0.701756
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.0175439	0.701756
RETINAL ARTERIES, TORTUOSITY OF	0.0175439	0.701756
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0175439	0.701756
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.01745598	0.6982392
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.017147370000000002	0.6858948000000001
NAVAJO NEUROHEPATOPATHY	0.016894529999999998	0.6757812
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.01607383	0.6429532
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.01607383	0.6429532
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.01607383	0.6429532
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0160574	0.642296
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.01586707	0.6346828000000001
PROPIONIC ACIDEMIA	0.01586707	0.6346828000000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.01545655	0.618262
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.01545655	0.618262
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.01545655	0.618262
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.01545655	0.618262
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0154431	0.6177239999999999
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.0154431	0.6177239999999999
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0154431	0.6177239999999999
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.01522014	0.6088056
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.01522014	0.6088056
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.01522014	0.6088056
RHABDOMYOLYSIS, ACUTE RECURRENT	0.01520371	0.6081484
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.01520371	0.6081484
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.015203709999999999	0.6081484
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.01481482	0.5925927999999999
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.01481482	0.5925927999999999
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.01481482	0.5925927999999999
CHANARIN-DORFMAN SYNDROME	0.01481482	0.5925927999999999
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.01481482	0.5925927999999999
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.01481482	0.5925927999999999
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.01479353	0.5917412
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.01479353	0.5917412
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.01479353	0.5917412
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.01457841	0.5831364
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.01457841	0.5831364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.01436956	0.5747824
BAKER-GORDON SYNDROME; BAGOS	0.01436956	0.5747824
HEART AND BRAIN MALFORMATION SYNDROME	0.01436956	0.5747824
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01422999	0.5691995999999999
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.01422999	0.5691995999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.01422999	0.5691995999999999
METACHROMATIC LEUKODYSTROPHY	0.01422999	0.5691995999999999
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.014176250000000001	0.56705
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.014176250000000001	0.56705
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.014176250000000001	0.56705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.014176250000000001	0.56705
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.014176250000000001	0.56705
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.01358826	0.5435304
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.01358826	0.5435304
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.01358826	0.5435304
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.01351587	0.5406348
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.01351587	0.5406348
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.013419219999999999	0.5367687999999999
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0133333	0.533332
CARPAL TUNNEL SYNDROME	0.0133333	0.533332
FOLATE MALABSORPTION, HEREDITARY	0.0133333	0.533332
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.0133333	0.533332
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.0133333	0.533332
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0133333	0.533332
NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE	0.0133333	0.533332
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0133333	0.533332
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.0133333	0.533332
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.0133333	0.533332
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.0133333	0.533332
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.0133333	0.533332
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0133333	0.533332
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.0133333	0.533332
NEUROPATHY, PAINFUL	0.0133333	0.533332
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0133333	0.533332
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0133333	0.533332
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.0133333	0.533332
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0133333	0.533332
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0133333	0.533332
THALIDOMIDE SUSCEPTIBILITY	0.0133333	0.533332
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0133333	0.533332
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.0133333	0.533332
CRANIAL NERVES, RECURRENT PARESIS OF	0.0133333	0.533332
#614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;MC5DN3;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5E TYPE	0.0133333	0.533332
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0133333	0.533332
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.0133333	0.533332
VALINEMIA	0.012801940000000001	0.5120776
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.012801940000000001	0.5120776
CYCLIC VOMITING SYNDROME	0.012801940000000001	0.5120776
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.012801940000000001	0.5120776
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.012801940000000001	0.5120776
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.012801940000000001	0.5120776
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.012801940000000001	0.5120776
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.01256553	0.5026212
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01256553	0.5026212
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.012525719999999999	0.5010287999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.012525719999999999	0.5010287999999999
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.012525719999999999	0.5010287999999999
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.012525719999999999	0.5010287999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0117284	0.46913600000000005
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0117284	0.46913600000000005
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.0117284	0.46913600000000005
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.01157538	0.4630152
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.01149199	0.4596796
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.01149199	0.4596796
LOWE OCULOCEREBRORENAL SYNDROME	0.01149199	0.4596796
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.01149199	0.4596796
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.01087471	0.4349884
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.01087471	0.4349884
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.01087471	0.4349884
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.01087471	0.4349884
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.01087471	0.4349884
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.01087471	0.4349884
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.01087471	0.4349884
PEROXISOME BIOGENESIS DISORDER 6B	0.010501839999999998	0.42007359999999994
TANGIER DISEASE; TGD	0.010501839999999998	0.42007359999999994
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00990099	0.3960396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00990099	0.3960396
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00990099	0.3960396
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00990099	0.3960396
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00990099	0.3960396
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00990099	0.3960396
DYSTONIA 23; DYT23	0.00990099	0.3960396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.00990099	0.3960396
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00990099	0.3960396
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00990099	0.3960396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.00990099	0.3960396
MYOPATHY, DISTAL, 1; MPD1	0.00990099	0.3960396
MELNICK-NEEDLES SYNDROME	0.00990099	0.3960396
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.3960396
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.00990099	0.3960396
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00990099	0.3960396
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00990099	0.3960396
JOUBERT SYNDROME 24	0.00990099	0.3960396
HYDROCEPHALUS, NORMAL-PRESSURE	0.00990099	0.3960396
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.3960396
TRYPTOPHANURIA WITH DWARFISM	0.00990099	0.3960396
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.3960396
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.00990099	0.3960396
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.00990099	0.3960396
BRITTLE CORNEA SYNDROME 2; BCS2	0.00990099	0.3960396
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00990099	0.3960396
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.3960396
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00990099	0.3960396
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.00990099	0.3960396
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00990099	0.3960396
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00990099	0.3960396
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.3960396
KUFOR-RAKEB SYNDROME	0.00990099	0.3960396
224550 DYSTONIA WITH RINGBINDEN	0.00990099	0.3960396
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.3960396
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00990099	0.3960396
ALZHEIMER DISEASE 3; AD	0.00990099	0.3960396
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.3960396
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00990099	0.3960396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00990099	0.3960396
COHEN-GIBSON SYNDROME; COGIS	0.00990099	0.3960396
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.3960396
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00990099	0.3960396
DYSTONIA 16; DYT16	0.00990099	0.3960396
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00990099	0.3960396
#156550 KNIEST DYSPLASIA	0.00990099	0.3960396
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.3960396
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00990099	0.3960396
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00990099	0.3960396
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00990099	0.3960396
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00988456	0.39538239999999997
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.00988456	0.39538239999999997
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00988456	0.39538239999999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00988456	0.39538239999999997
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00988456	0.39538239999999997
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00988456	0.39538239999999997
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00988456	0.39538239999999997
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.00964815	0.385926
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00964815	0.385926
#614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	0.00964815	0.385926
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00964815	0.385926
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.00964815	0.385926
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.00964815	0.385926
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.00964815	0.385926
DE SANCTIS-CACCHIONE SYNDROME	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00964815	0.385926
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00964815	0.385926
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00964815	0.385926
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00964815	0.385926
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.00964815	0.385926
#614455 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE;;CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS	0.00964815	0.385926
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00964815	0.385926
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00964815	0.385926
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00964815	0.385926
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00964815	0.385926
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	0.00964815	0.385926
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.00964815	0.385926
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.00964815	0.385926
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00964815	0.385926
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00964815	0.385926
SPINOCEREBELLAR ATAXIA 18	0.00964815	0.385926
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.00964815	0.385926
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.00964815	0.385926
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00964815	0.385926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.00964815	0.385926
#300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	0.00964815	0.385926
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00964815	0.385926
ADDUCTED THUMBS SYNDROME	0.00925926	0.3703704
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00925926	0.3703704
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00925926	0.3703704
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00925926	0.3703704
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00925926	0.3703704
BETHLEM MYOPATHY 1	0.00925926	0.3703704
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00925926	0.3703704
STROMME SYNDROME; STROMS	0.00925926	0.3703704
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00925926	0.3703704
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00925926	0.3703704
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00925926	0.3703704
VICI SYNDROME; VICIS	0.00925926	0.3703704
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00925926	0.3703704
CARNITINE DEFICIENCY, MYOPATHIC	0.00925926	0.3703704
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00925926	0.3703704
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.00925926	0.3703704
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00925926	0.3703704
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00925926	0.3703704
AXIAL OSTEOMALACIA	0.00925926	0.3703704
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.00925926	0.3703704
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00925926	0.3703704
SALIH MYOPATHY; SALMY	0.00925926	0.3703704
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00925926	0.3703704
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00925926	0.3703704
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00925926	0.3703704
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00925926	0.3703704
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00925926	0.3703704
CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	0.00925926	0.3703704
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00925926	0.3703704
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00925926	0.3703704
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00925926	0.3703704
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00925926	0.3703704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00925926	0.3703704
XANTHINURIA, TYPE I	0.00925926	0.3703704
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00925926	0.3703704
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.00925926	0.3703704
300270 ADRENOMYODYSTROPHY	0.00925926	0.3703704
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00925926	0.3703704
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00925926	0.3703704
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.00925926	0.3703704
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00925926	0.3703704
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00925926	0.3703704
STORMORKEN SYNDROME; STRMK	0.00925926	0.3703704
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00925926	0.3703704
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00925926	0.3703704
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00925926	0.3703704
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00925926	0.3703704
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.00925926	0.3703704
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00925926	0.3703704
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00925926	0.3703704
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00925926	0.3703704
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00925926	0.3703704
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00925926	0.3703704
IMMUNODEFICIENCY 9; IMD9	0.00925926	0.3703704
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00925926	0.3703704
MARINESCO-SJOGREN SYNDROME; MSS	0.00925926	0.3703704
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00925926	0.3703704
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00925926	0.3703704
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00925926	0.3703704
IMMUNODEFICIENCY 10; IMD10	0.00925926	0.3703704
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00925926	0.3703704
#170400 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1;;HYPOKALEMIC PERIODIC PARALYSIS; HOKPP	0.00925926	0.3703704
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.00925926	0.3703704
FINGERPRINT BODY MYOPATHY	0.00925926	0.3703704
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00925926	0.3703704
HYPOPHOSPHATASIA, CHILDHOOD	0.00925926	0.3703704
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00925926	0.3703704
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00862069	0.3448276
WARBURG MICRO SYNDROME 1	0.00862069	0.3448276
GLYCOGEN STORAGE DISEASE IB	0.00862069	0.3448276
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00862069	0.3448276
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00862069	0.3448276
DESBUQUOIS DYSPLASIA 1	0.00862069	0.3448276
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00862069	0.3448276
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.00862069	0.3448276
THROMBOCYTOPENIA 6	0.00862069	0.3448276
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00862069	0.3448276
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.00862069	0.3448276
FORSYTHE-WAKELING SYNDROME; FWS	0.00862069	0.3448276
MENKES DISEASE	0.00862069	0.3448276
MACS SYNDROME	0.00862069	0.3448276
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00862069	0.3448276
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00862069	0.3448276
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00862069	0.3448276
PREMATURE OVARIAN FAILURE 2B	0.00862069	0.3448276
OVARIAN DYSGENESIS 8; ODG8	0.00862069	0.3448276
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00862069	0.3448276
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00862069	0.3448276
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00862069	0.3448276
GERODERMA OSTEODYSPLASTICUM; GO	0.00862069	0.3448276
PRIMROSE SYNDROME; PRIMS	0.00862069	0.3448276
LICHTENSTEIN SYNDROME	0.00862069	0.3448276
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00862069	0.3448276
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	0.00862069	0.3448276
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.00862069	0.3448276
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00862069	0.3448276
LATHOSTEROLOSIS	0.00862069	0.3448276
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.00862069	0.3448276
Rothmund-Thomson syndrome	0.00862069	0.3448276
GLYCOGEN STORAGE DISEASE IA	0.00862069	0.3448276
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00862069	0.3448276
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00862069	0.3448276
ODONTOCHONDRODYSPLASIA; ODCD	0.00862069	0.3448276
#613418 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15;;OSTEOPOROSIS, SUSCEPTIBILITY TO;;METAPHYSEAL FRACTURE, SUSCEPTIBILITY TO;;COMPRESSION FRACTURE, SUSCEPTIBILITY TO	0.00862069	0.3448276
OVARIAN DYSGENESIS 1	0.00862069	0.3448276
EHLERS-DANLOS SYNDROME, TYPE VI	0.00862069	0.3448276
#615468 IMMUNODEFICIENCY 12; IMD12	0.00862069	0.3448276
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00862069	0.3448276
SHASHI-PENA SYNDROME; SHAPNS	0.00862069	0.3448276
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00862069	0.3448276
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00862069	0.3448276
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.00862069	0.3448276
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00862069	0.3448276
OSTEOPOROSIS, JUVENILE	0.00862069	0.3448276
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00862069	0.3448276
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00862069	0.3448276
MORQUIO SYNDROME A	0.00862069	0.3448276
HEMOCHROMATOSIS, TYPE 1	0.00862069	0.3448276
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.00862069	0.3448276
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	0.00862069	0.3448276
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00862069	0.3448276
WERNER SYNDROME; WRN	0.00862069	0.3448276
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00862069	0.3448276
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00862069	0.3448276
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.00862069	0.3448276
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00862069	0.3448276
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00862069	0.3448276
FRANK-TER HAAR SYNDROME; FTHS	0.00862069	0.3448276
OSTEOPOROSIS	0.00862069	0.3448276
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00862069	0.3448276
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00862069	0.3448276
#259450 BRUCK SYNDROME 1; BRKS1	0.00862069	0.3448276
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00862069	0.3448276
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.00862069	0.3448276
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00862069	0.3448276
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00862069	0.3448276
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00862069	0.3448276
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00862069	0.3448276
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.00862069	0.3448276
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00862069	0.3448276
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00862069	0.3448276
LOEYS-DIETZ SYNDROME 3; LDS3	0.00862069	0.3448276
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00862069	0.3448276
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00862069	0.3448276
EMANUEL SYNDROME	0.00819672	0.32786879999999996
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00819672	0.32786879999999996
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00819672	0.32786879999999996
KLEEFSTRA SYNDROME	0.00819672	0.32786879999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00819672	0.32786879999999996
LYMPHEDEMA, HEREDITARY, III	0.00819672	0.32786879999999996
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00819672	0.32786879999999996
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00819672	0.32786879999999996
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00819672	0.32786879999999996
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00819672	0.32786879999999996
BRANCHIOOCULOFACIAL SYNDROME	0.00819672	0.32786879999999996
WEBB-DATTANI SYNDROME; WEDAS	0.00819672	0.32786879999999996
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00819672	0.32786879999999996
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00819672	0.32786879999999996
RETT SYNDROME, CONGENITAL VARIANT	0.00819672	0.32786879999999996
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00819672	0.32786879999999996
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00819672	0.32786879999999996
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00819672	0.32786879999999996
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00819672	0.32786879999999996
CODAS SYNDROME	0.00819672	0.32786879999999996
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00819672	0.32786879999999996
MIRAGE SYNDROME; MIRAGE	0.00819672	0.32786879999999996
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00819672	0.32786879999999996
MEIER-GORLIN SYNDROME 2; MGORS2	0.00819672	0.32786879999999996
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00819672	0.32786879999999996
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00819672	0.32786879999999996
RETT SYNDROME; RTT	0.00819672	0.32786879999999996
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00819672	0.32786879999999996
GASTROESOPHAGEAL REFLUX	0.00819672	0.32786879999999996
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00819672	0.32786879999999996
611961 STEVENSON-CAREY SYNDROME	0.00819672	0.32786879999999996
#251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY;;METHYLMALONYL-CoA RACEMASE DEFICIENCY;;METHYLMALONIC ACIDURIA III, FORMERLYMETHYLMALONYL-CoA EPIMERASE DEFICIENCY WITH SEPIAPTERIN REDUCTASEDEFICIENCY, INCLUDED	0.00819672	0.32786879999999996
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00819672	0.32786879999999996
SWEENEY-COX SYNDROME; SWCOS	0.00819672	0.32786879999999996
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.00819672	0.32786879999999996
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00819672	0.32786879999999996
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00819672	0.32786879999999996
CRI-DU-CHAT SYNDROME	0.00819672	0.32786879999999996
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.00819672	0.32786879999999996
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00819672	0.32786879999999996
MEIER-GORLIN SYNDROME 6; MGORS6	0.00819672	0.32786879999999996
CHOPS SYNDROME; CHOPS	0.00819672	0.32786879999999996
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00819672	0.32786879999999996
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00819672	0.32786879999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00819672	0.32786879999999996
#614266 BARRETT ESOPHAGUS;;BARRETT METAPLASIAADENOCARCINOMA OF ESOPHAGUS, INCLUDED	0.00819672	0.32786879999999996
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00819672	0.32786879999999996
COFFIN-SIRIS SYNDROME 6; CSS6	0.00819672	0.32786879999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00819672	0.32786879999999996
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00819672	0.32786879999999996
MEIER-GORLIN SYNDROME 3; MGORS3	0.00819672	0.32786879999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00819672	0.32786879999999996
Xq28 (MECP2) duplication	0.00819672	0.32786879999999996
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00819672	0.32786879999999996
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.00819672	0.32786879999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00819672	0.32786879999999996
MEIER-GORLIN SYNDROME 1; MGORS1	0.00819672	0.32786879999999996
CORNELIA DE LANGE SYNDROME 1	0.00819672	0.32786879999999996
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00819672	0.32786879999999996
POTOCKI-LUPSKI SYNDROME	0.00819672	0.32786879999999996
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00819672	0.32786879999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.00819672	0.32786879999999996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00819672	0.32786879999999996
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00819672	0.32786879999999996
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00819672	0.32786879999999996
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00819672	0.32786879999999996
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00819672	0.32786879999999996
TOWNES-BROCKS SYNDROME 1; TBS1	0.00819672	0.32786879999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00819672	0.32786879999999996
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00819672	0.32786879999999996
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00819672	0.32786879999999996
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00819672	0.32786879999999996
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00819672	0.32786879999999996
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00819672	0.32786879999999996
MEIER-GORLIN SYNDROME 5; MGORS5	0.00819672	0.32786879999999996
POPOV-CHANG SYNDROME; POPCHAS	0.00819672	0.32786879999999996
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00819672	0.32786879999999996
BOHRING-OPITZ SYNDROME	0.00819672	0.32786879999999996
SCHAAF-YANG SYNDROME; SHFYNG	0.00819672	0.32786879999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00819672	0.32786879999999996
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.00819672	0.32786879999999996
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.2898552
MOWAT-WILSON SYNDROME; MOWS	0.00724638	0.2898552
GALACTOSEMIA	0.00724638	0.2898552
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.00724638	0.2898552
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.00724638	0.2898552
CAROLI DISEASE, ISOLATED	0.00724638	0.2898552
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.2898552
GALACTOSE EPIMERASE DEFICIENCY	0.00724638	0.2898552
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.2898552
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.00724638	0.2898552
MAPLE SYRUP URINE DISEASE; MSUD	0.00724638	0.2898552
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.2898552
CHROMOSOME 19p13.13 DELETION SYNDROME	0.00724638	0.2898552
ARGININOSUCCINIC ACIDURIA	0.00724638	0.2898552
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.2898552
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00724638	0.2898552
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.2898552
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.00724638	0.2898552
KRABBE DISEASE	0.00724638	0.2898552
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00724638	0.2898552
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.2898552
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00724638	0.2898552
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.00724638	0.2898552
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.2898552
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.00724638	0.2898552
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00724638	0.2898552
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00724638	0.2898552
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.00724638	0.2898552
HYPERLIPOPROTEINEMIA, TYPE I	0.00724638	0.2898552
MEVALONIC ACIDURIA; MEVA	0.00724638	0.2898552
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.2898552
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.00724638	0.2898552
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00724638	0.2898552
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.2898552
INFANTILE LIVER FAILURE SYNDROME 2	0.00724638	0.2898552
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00724638	0.2898552
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00724638	0.2898552
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00724638	0.2898552
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00724638	0.2898552
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.2898552
HYPOPHOSPHATASIA, INFANTILE	0.00724638	0.2898552
ACID PHOSPHATASE DEFICIENCY	0.00724638	0.2898552
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00724638	0.2898552
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.00724638	0.2898552
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.2898552
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.2898552
LESCH-NYHAN SYNDROME; LNS	0.00724638	0.2898552
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.2898552
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00724638	0.2898552
EPISODIC ATAXIA, TYPE 6	0.00724638	0.2898552
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00724638	0.2898552
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00724638	0.2898552
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00724638	0.2898552
LIVER FAILURE, INFANTILE, TRANSIENT	0.00724638	0.2898552
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.2898552
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.2898552
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.00724638	0.2898552
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00724638	0.2898552
VISCERAL MYOPATHY; VSCM	0.00724638	0.2898552
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00724638	0.2898552
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00724638	0.2898552
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00724638	0.2898552
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.2898552
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00724638	0.2898552
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.2898552
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00724638	0.2898552
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.2898552
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.2898552
CITRULLINEMIA, CLASSIC	0.00724638	0.2898552
HYPOADRENOCORTICISM, FAMILIAL	0.00724638	0.2898552
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.2898552
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00724638	0.2898552
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00724638	0.2898552
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00724638	0.2898552
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.2898552
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00724638	0.2898552
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.2898552
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.2898552
PORPHYRIA, ACUTE HEPATIC	0.00724638	0.2898552
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00724638	0.2898552
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.2898552
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00724638	0.2898552
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.00724638	0.2898552
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00724638	0.2898552
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00724638	0.2898552
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00724638	0.2898552
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00724638	0.2898552
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00724638	0.2898552
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.2898552
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.2898552
FUMARASE DEFICIENCY; FMRD	0.00617284	0.24691359999999998
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00617284	0.24691359999999998
#300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A;;CSNB, INCOMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2	0.00617284	0.24691359999999998
#610359 RETINITIS PIGMENTOSA 33; RP33	0.00617284	0.24691359999999998
#606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISMALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED	0.00617284	0.24691359999999998
CONE DYSTROPHY 4	0.00617284	0.24691359999999998
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00617284	0.24691359999999998
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00617284	0.24691359999999998
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00617284	0.24691359999999998
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00617284	0.24691359999999998
#165550 OPTIC NERVE HYPOPLASIA, BILATERALOPTIC NERVE APLASIA, BILATERAL, INCLUDED	0.00617284	0.24691359999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00617284	0.24691359999999998
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.00617284	0.24691359999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00617284	0.24691359999999998
RETINITIS PIGMENTOSA 27; RP27	0.00617284	0.24691359999999998
XFE PROGEROID SYNDROME; XFEPS	0.00617284	0.24691359999999998
MUCOLIPIDOSIS IV; ML4	0.00617284	0.24691359999999998
COHEN SYNDROME	0.00617284	0.24691359999999998
#606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV	0.00617284	0.24691359999999998
N SYNDROME	0.00617284	0.24691359999999998
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00617284	0.24691359999999998
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00617284	0.24691359999999998
#603649 CONE-ROD DYSTROPHY 7; CORD7	0.00617284	0.24691359999999998
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00617284	0.24691359999999998
#613428 RETINITIS PIGMENTOSA 54; RP54	0.00617284	0.24691359999999998
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.00617284	0.24691359999999998
#614180 RETINITIS PIGMENTOSA 61; RP61	0.00617284	0.24691359999999998
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00617284	0.24691359999999998
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.00617284	0.24691359999999998
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00617284	0.24691359999999998
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00617284	0.24691359999999998
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00617284	0.24691359999999998
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.00617284	0.24691359999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00617284	0.24691359999999998
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00617284	0.24691359999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00617284	0.24691359999999998
COFFIN-SIRIS SYNDROME 2; CSS2	0.00617284	0.24691359999999998
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00617284	0.24691359999999998
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00617284	0.24691359999999998
ALBINISM, OCULAR, TYPE I	0.00617284	0.24691359999999998
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00617284	0.24691359999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00617284	0.24691359999999998
CROUZON SYNDROME	0.00617284	0.24691359999999998
HYPERTRYPTOPHANEMIA; HYPTRP	0.00617284	0.24691359999999998
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00617284	0.24691359999999998
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00617284	0.24691359999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00617284	0.24691359999999998
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00617284	0.24691359999999998
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00617284	0.24691359999999998
RETINITIS PIGMENTOSA 20	0.00617284	0.24691359999999998
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00617284	0.24691359999999998
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00617284	0.24691359999999998
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00617284	0.24691359999999998
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00617284	0.24691359999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00617284	0.24691359999999998
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00617284	0.24691359999999998
SPASTIC PARAPLEGIA 16, X-LINKED	0.00617284	0.24691359999999998
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00617284	0.24691359999999998
BLUE CONE MONOCHROMACY; BCM	0.00617284	0.24691359999999998
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00617284	0.24691359999999998
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00617284	0.24691359999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00617284	0.24691359999999998
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00617284	0.24691359999999998
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.00617284	0.24691359999999998
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00617284	0.24691359999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00617284	0.24691359999999998
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00617284	0.24691359999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00617284	0.24691359999999998
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00617284	0.24691359999999998
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.00617284	0.24691359999999998
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00617284	0.24691359999999998
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.00617284	0.24691359999999998
JOUBERT SYNDROME 2	0.00617284	0.24691359999999998
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.00617284	0.24691359999999998
#613268 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00617284	0.24691359999999998
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.00617284	0.24691359999999998
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00617284	0.24691359999999998
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00617284	0.24691359999999998
#607921 RETINITIS PIGMENTOSA 30; RP30	0.00617284	0.24691359999999998
#613856 ACHROMATOPSIA 4; ACHM4	0.00617284	0.24691359999999998
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00617284	0.24691359999999998
#608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A;;LATTICE CORNEAL DYSTROPHY, TYPE IIIA	0.00617284	0.24691359999999998
COFFIN-SIRIS SYNDROME 3; CSS3	0.00617284	0.24691359999999998
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00617284	0.24691359999999998
JOUBERT SYNDROME 3; JBTS3	0.00617284	0.24691359999999998
CREUTZFELDT-JAKOB DISEASE; CJD	0.00617284	0.24691359999999998
GILLESPIE SYNDROME; GLSP	0.00617284	0.24691359999999998
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00617284	0.24691359999999998
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00617284	0.24691359999999998
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00617284	0.24691359999999998
#615431 MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23	0.00617284	0.24691359999999998
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00617284	0.24691359999999998
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.00617284	0.24691359999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00617284	0.24691359999999998
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00617284	0.24691359999999998
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00617284	0.24691359999999998
#612775 CONE-ROD DYSTROPHY 9; CORD9	0.00617284	0.24691359999999998
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00617284	0.24691359999999998
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00617284	0.24691359999999998
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00617284	0.24691359999999998
#613827 RETINITIS PIGMENTOSA 48; RP48	0.00617284	0.24691359999999998
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00617284	0.24691359999999998
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00617284	0.24691359999999998
JABERI-ELAHI SYNDROME; JABELS	0.00617284	0.24691359999999998
Helsmoortel-van der Aa syndrome	0.00617284	0.24691359999999998
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00617284	0.24691359999999998
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00617284	0.24691359999999998
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00617284	0.24691359999999998
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00617284	0.24691359999999998
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00617284	0.24691359999999998
COFFIN-SIRIS SYNDROME 4; CSS4	0.00617284	0.24691359999999998
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00617284	0.24691359999999998
FILIPPI SYNDROME; FLPIS	0.00617284	0.24691359999999998
#613758 RETINITIS PIGMENTOSA 47; RP47	0.00617284	0.24691359999999998
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00617284	0.24691359999999998
BIRDSHOT CHORIORETINOPATHY	0.00617284	0.24691359999999998
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.00617284	0.24691359999999998
COFFIN-SIRIS SYNDROME 1; CSS1	0.00617284	0.24691359999999998
CONE-ROD DYSTROPHY 17; CORD17	0.00617284	0.24691359999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.00617284	0.24691359999999998
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00555556	0.22222240000000001
GLYCOGEN STORAGE DISEASE VII	0.00555556	0.22222240000000001
KEARNS-SAYRE SYNDROME; KSS	0.00555556	0.22222240000000001
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.00555556	0.22222240000000001
COWCHOCK SYNDROME; COWCK	0.00555556	0.22222240000000001
EPISODIC ATAXIA, TYPE 8	0.00555556	0.22222240000000001
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00555556	0.22222240000000001
SPONDYLOOCULAR SYNDROME; SOS	0.00555556	0.22222240000000001
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00555556	0.22222240000000001
GLYCOGEN STORAGE DISEASE V; GSD5	0.00555556	0.22222240000000001
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00555556	0.22222240000000001
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00555556	0.22222240000000001
#613507 GLYCOGEN STORAGE DISEASE XV; GSD15;;GSD XV;;GLYCOGENIN DEFICIENCY;;GYG1 DEFICIENCY	0.00555556	0.22222240000000001
AMYOTROPHIC LATERAL SCLEROSIS 1	0.00555556	0.22222240000000001
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00555556	0.22222240000000001
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00555556	0.22222240000000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00555556	0.22222240000000001
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00555556	0.22222240000000001
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00555556	0.22222240000000001
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00555556	0.22222240000000001
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.00555556	0.22222240000000001
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00555556	0.22222240000000001
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00555556	0.22222240000000001
#614808 AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	0.00555556	0.22222240000000001
#615731 NEMALINE MYOPATHY 9; NEM9	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00555556	0.22222240000000001
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00555556	0.22222240000000001
PYLE DISEASE; PYL	0.00555556	0.22222240000000001
#613435 AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	0.00555556	0.22222240000000001
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00555556	0.22222240000000001
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00555556	0.22222240000000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00555556	0.22222240000000001
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.00555556	0.22222240000000001
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00555556	0.22222240000000001
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00555556	0.22222240000000001
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00555556	0.22222240000000001
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00555556	0.22222240000000001
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00555556	0.22222240000000001
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00555556	0.22222240000000001
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00555556	0.22222240000000001
GLYCOGEN STORAGE DISEASE IXB	0.00555556	0.22222240000000001
%300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	0.00555556	0.22222240000000001
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00555556	0.22222240000000001
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00555556	0.22222240000000001
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00555556	0.22222240000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00555556	0.22222240000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00555556	0.22222240000000001
SUPRABULBAR PARESIS, CONGENITAL	0.00555556	0.22222240000000001
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00555556	0.22222240000000001
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00555556	0.22222240000000001
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00555556	0.22222240000000001
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	0.00555556	0.22222240000000001
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00555556	0.22222240000000001
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00555556	0.22222240000000001
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00555556	0.22222240000000001
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.00555556	0.22222240000000001
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.00555556	0.22222240000000001
#613954 AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS14	0.00555556	0.22222240000000001
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00555556	0.22222240000000001
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00555556	0.22222240000000001
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00555556	0.22222240000000001
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00555556	0.22222240000000001
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00555556	0.22222240000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00555556	0.22222240000000001
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00555556	0.22222240000000001
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00555556	0.22222240000000001
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00555556	0.22222240000000001
EPISODIC ATAXIA, TYPE 7; EA7	0.00555556	0.22222240000000001
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	0.00555556	0.22222240000000001
MUSCLE GLYCOGENOSIS, X-LINKED	0.00555556	0.22222240000000001
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00531915	0.212766
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.00531915	0.212766
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00531915	0.212766
PIERSON SYNDROME	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00531915	0.212766
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00531915	0.212766
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00531915	0.212766
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00531915	0.212766
USHER SYNDROME, TYPE IE; USH1E	0.00531915	0.212766
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00531915	0.212766
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.00531915	0.212766
SPINOCEREBELLAR ATAXIA 1	0.00531915	0.212766
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00531915	0.212766
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00531915	0.212766
GLYCOGEN STORAGE DISEASE II	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.00531915	0.212766
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.00531915	0.212766
MYOPATHY, CENTRONUCLEAR, 5	0.00531915	0.212766
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.00531915	0.212766
RICHARDS-RUNDLE SYNDROME; RRNS	0.00531915	0.212766
DEAFNESS, X-LINKED 5; DFNX5	0.00531915	0.212766
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00531915	0.212766
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.00531915	0.212766
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00531915	0.212766
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00531915	0.212766
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.00531915	0.212766
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.00531915	0.212766
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00531915	0.212766
#253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE	0.00531915	0.212766
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00531915	0.212766
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00531915	0.212766
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00531915	0.212766
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00531915	0.212766
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00531915	0.212766
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.00531915	0.212766
WIEACKER-WOLFF SYNDROME	0.00531915	0.212766
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.00531915	0.212766
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00531915	0.212766
#607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE;;CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE	0.00531915	0.212766
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00531915	0.212766
ALAGILLE SYNDROME 1; ALGS1	0.00531915	0.212766
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00531915	0.212766
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00531915	0.212766
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00531915	0.212766
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00531915	0.212766
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00531915	0.212766
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.00531915	0.212766
RADICULONEUROPATHY, FATAL NEONATAL	0.00531915	0.212766
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00531915	0.212766
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0043289999999999995	0.17315999999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.0043289999999999995	0.17315999999999998
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0043289999999999995	0.17315999999999998
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0043289999999999995	0.17315999999999998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0043289999999999995	0.17315999999999998
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.0043289999999999995	0.17315999999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0043289999999999995	0.17315999999999998
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.0043289999999999995	0.17315999999999998
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA 43; SCA43	0.0043289999999999995	0.17315999999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0043289999999999995	0.17315999999999998
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0043289999999999995	0.17315999999999998
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.0043289999999999995	0.17315999999999998
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0043289999999999995	0.17315999999999998
GLYCINE ENCEPHALOPATHY; GCE	0.0043289999999999995	0.17315999999999998
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.0043289999999999995	0.17315999999999998
#605726 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE;;NEUROPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE; HMNJ;;SPINAL MUSCULAR ATROPHY, JERASH TYPE	0.0043289999999999995	0.17315999999999998
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0043289999999999995	0.17315999999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0043289999999999995	0.17315999999999998
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0043289999999999995	0.17315999999999998
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0043289999999999995	0.17315999999999998
FACIAL SPASM	0.0043289999999999995	0.17315999999999998
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.0043289999999999995	0.17315999999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0043289999999999995	0.17315999999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.0043289999999999995	0.17315999999999998
IMMUNODEFICIENCY 23; IMD23	0.0043289999999999995	0.17315999999999998
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0043289999999999995	0.17315999999999998
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0043289999999999995	0.17315999999999998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.0043289999999999995	0.17315999999999998
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	0.0043289999999999995	0.17315999999999998
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.0043289999999999995	0.17315999999999998
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0043289999999999995	0.17315999999999998
CHROMOSOME 2q37 DELETION SYNDROME	0.0043289999999999995	0.17315999999999998
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0043289999999999995	0.17315999999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0043289999999999995	0.17315999999999998
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.0043289999999999995	0.17315999999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0043289999999999995	0.17315999999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0043289999999999995	0.17315999999999998
PELIZAEUS-MERZBACHER DISEASE	0.0043289999999999995	0.17315999999999998
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0043289999999999995	0.17315999999999998
#611722 KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY;;SAPOSIN A DEFICIENCY	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0043289999999999995	0.17315999999999998
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0043289999999999995	0.17315999999999998
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.0043289999999999995	0.17315999999999998
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.0043289999999999995	0.17315999999999998
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0043289999999999995	0.17315999999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.0043289999999999995	0.17315999999999998
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.0043289999999999995	0.17315999999999998
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0043289999999999995	0.17315999999999998
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0043289999999999995	0.17315999999999998
PERRAULT SYNDROME 5; PRLTS5	0.0043289999999999995	0.17315999999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0043289999999999995	0.17315999999999998
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0043289999999999995	0.17315999999999998
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.0043289999999999995	0.17315999999999998
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0043289999999999995	0.17315999999999998
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.0043289999999999995	0.17315999999999998
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0043289999999999995	0.17315999999999998
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.0043289999999999995	0.17315999999999998
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.0043289999999999995	0.17315999999999998
VERVERI-BRADY SYNDROME; VERBRAS	0.0043289999999999995	0.17315999999999998
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0043289999999999995	0.17315999999999998
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0043289999999999995	0.17315999999999998
LOEYS-DIETZ SYNDROME 5	0.0043289999999999995	0.17315999999999998
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0043289999999999995	0.17315999999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.0043289999999999995	0.17315999999999998
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.0043289999999999995	0.17315999999999998
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0043289999999999995	0.17315999999999998
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0043289999999999995	0.17315999999999998
NEMALINE MYOPATHY 4	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.0043289999999999995	0.17315999999999998
ADIE PUPIL	0.0043289999999999995	0.17315999999999998
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0043289999999999995	0.17315999999999998
#615185 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF	0.0043289999999999995	0.17315999999999998
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0043289999999999995	0.17315999999999998
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.0043289999999999995	0.17315999999999998
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.0043289999999999995	0.17315999999999998
REFSUM DISEASE	0.0043289999999999995	0.17315999999999998
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0043289999999999995	0.17315999999999998
